ABSTRACT: New studies were undertaken to verify the previous findings of increased urinary excretion of taurine, in the basal state and after challenge with a taurine load, in Friedreich's disease. Particular attention was paid to possible causes of error such as weight, muscle mass, creatine and creatinine excretion, variability with time and appropriate control groups. Although the overall findings were confirmed, their interpretation is open to question because of all these factors of error. Many possibilities must still be further explored to account for the apparent taurine retention defect observed in many cases of Friedreich's disease. RESUME: De nouvelles etudes furent entreprises pour verifier les observations anterieures d'excretion urinaire augmentee de taurine, a 1'etat de base et apres surcharge, dans la maladie de Friedreich. Une attention toute particuliere fut portee a plusieurs causes d'erreurs possibles: poids, masse musculaire, excretion de la creatinine et de la creatine, variabilite dans le temps et utilisation de groupes temoins appropries. Quoique dans l'ensemble les observations anterieures furent confirmees, il faut emettre des reserves sur l'interpretation finale, a cause de tous ces facteurs d'erreurs. II faut encore explorer en detail plusieurs possibility avant de pouvoir expliquer le defaut apparent dans la retention de la taurine chez plusieurs patients souffrant de la maladie de Friedreich.
It was postulated (Barbeau, 1982 ) that subjects suffering from Friedreich's ataxia have a reduced capacity for the retention of taurine in the kidney. One of the possibilities explored was a defect in the TH reabsorption system situated in the border of renal tubule cells (Godman et al., 1982) with low capacity but high specificity for taurine. Such a transport defect, if confirmed, would be a major contributory factor to the development of the symptoms of Friedreich's ataxia, particularly the primary symptoms including cardiomyopathy, absence of reflexes and dorsal column involvement.
This hypothesis was supported by two observations: 1) increased urinary excretion of taurine in F.A. patients (Lemieux et al., 1976) ;
2) studies with a taurine challenge to identify different types of urinary excretion of the amino acid Fillaetal., 1979) .
In the philosophy of the Quebec Cooperative Study it is imperative to submit each new finding, or hypothesis, to the scrutiny of other laboratories. Because of a few uncertainties in the interpretation of the basic data, the present studies were undertaken. These questions concern both the observation of increased urinary excretion of taurine and the results of challenge tests:
(1) The distribution of taurine in the body is not homogeneous, the muscles, including the heart, containing nearly 70% of the total. Because of this distribution any pathology affecting these muscles could be reflected in abnormal urinary excretion of taurine. Such was indeed the case in conditions of stress, corticosteroid therapy, idiopathic scoliosis and familial cerebral dyssynergy (Fillaetal., 1979; Goodman etal., 1980) .Thus the increased loss of taurine could equally be due to a decreased tissue reservoir because of the smaller mass.
(2) The results of the original challenge tests were based on a uniform load of 250 mg of taurine, independent of the weight of the individual, although the range of weights in these individuals, all adults, was not great (mean 45 kilograms for the women and 63 kilograms for the men, thus 3.96 to 5.56 mg of taurine per kilogram).
The measurement of creatine and creatinine in different subjects: Friedreich's disease (F.A.), muscular dystrophy and healthy controls permits the evaluation of different parameters: creatine metabolism; creatine/creatinine ratio in different pathological states; utility of creatinine as a factor of reference for the measurement of taurine, and a comparison of the findings in F.A. subjects with others having a similar muscle mass (Applegarth and Ross, 1975; Dechaux et al., 1978) .
The objective of this study was thus to further investigate the excretion of taurine by evaluating the influence of these parameters upon the proposed hypothesis, and upon the validity of the original data.
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Test population
12 subjects with Friedreich's ataxia (from Sherbrooke) 3 subjects with muscular dystrophy 6 controls age matched to the ataxic patients
Taurine challenge
The dose of taurine used was strictly 4 mg/kg. As shown by Goodman and his collaborators, this dose produces the greatest difference between genotypes (Conolly and Connolly et al., 1979; Goodman et al., 1980; Goodman and Connolly, 1982) . The test was started between 8 and 9 am, after an overnight fast. The subjects had all completed a urine collection for the 24 hours preceeding the test (time zero). Taurine was administered orally in lOccofwater. Urine collection were made after 2, 4 and 6 hours. The laboratory techniques used were: for creatine and creatinine -O' Brien et al. (1968) , for alpha-amino-nitrogen- Wells (1969) , and for taurine -Lemieux etal. (1976) . (Table I) The 24 hours excretion of taurine, when corrected for weight, shows that in 1976, 11 of 15 cases of F.A. had values within the range of normal subjects. In 1983 of the 12 subjects surviving 7 had values within the normal range. In 1983,7 of the 12 subjects had taurine excretion greater than in 1976, the other five had values below those in 1976. Two of the three cases of muscular dystrophy had values within the normal range. Age   22  21  22  8  13  26  25  15  14  7  12  9  13  9  16  12  17  23  28  21  14- Creatinine in blood and urine In 1976 (Table 2 ) of 18 F.A. subjects, 10 had subnormal 24 hour creatinine level expressed as mg/24 hours, but when expressed as mg/kg/24 hours only one had a value below the normal range. The same phenomenon was seen in 1983 (Table 3) where 7 of 12 had sub-normal excretion in terms of creatinine/24 hours, but only 2 of 12 had low values expressed as mg/kg/24 hours. The three muscular dystrophy patients had low creatinine excretion. The creatine/creatinine ratio was lower than normal in most F.A. cases but was greatly increased in muscular dystrophy.
RESULTS
Excretion of taurine
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Taurine levels after challenge
As can be seen (Fig. 1) , the mean excretion of taurine in response to the challenge was greater for the F.A. cases than for the controls, but very much less than for the muscular dystrophy patients. The pattern of excretion was similar for F.A. and control subjects.
A comparable difference was obtained when the excretion was calculated in terms of alpha-amino-nitrogen excretion, although the difference between the three groups of subjects was less marked (Table 5 , Fig. 1 and 2) . The shape of the curves, if not the amplitude, confirms the pattern observed by Barbeau et al. (1982) , whose cases are older.
DISCUSSION
The measurement of urinary creatinine is widely used as an index of excretion. However, this is subject to variation accord- ingto muscle mass, muscular activity, intake of creatine (muscle meat) and, evidently muscle metabolism and renal function. Hence, when utilising this parameter to compare different groups of subjects, it is obviously necessary that these variables be constant between the groups.
In the 1983 study, the absolute excretion of creatinine in 24 hours was, for the majority of F.A. subjects, lower than for healthy subjects of similar age, but when expressed in terms of body weight the excretion in F.A. subjects was normal. It is evident, from this, that creatinine as such is not a reliable index for the study of excretion in F.A. subjects. Furthermore, the abnormal creatine/creatinine ratio in F.A. subjects would indicate abnormal muscle metabolism, which also must discredit the use of creatinine.
We included some cases of muscular dystrophy in the study to determine if subjects who had similar physical handicap would be a more appropriate test group. As can be seen (Table  3 ) the creatinine excretion was grossly abnormal in that group.
In comparing the results obtained for creatinine in 1976 and 1983 (Tables 2, 3 and 4) it is evident that the results are similar, that the absolute excretion of creatinine is below normal limits in most F.A. subjects. A disquieting feature is the wide variation in creatinine excretion in the same individuals (Table 4) .
While the age may have been a factor in 1976, all were adults by 1983, and it now appears that weight, or more probably muscle mass, is the most important factor. The interpretation of taurine excretion expressed uniquely in terms of creatinine is therefore open to criticism in such subjects.
Using a second parameter which, perhaps, relates more directly to taurine -the excretion of alpha-amino-nitrogen -there was also increased excretion of taurine, although less marked. It would be worthwhile investigating further to determine if this parameter (alpha-amino-nitrogen) is a more reliable index of amino acid excretion than creatinine. Others (Seashore et al., 1981) suggest the use of the B-methylhistidine/creatinine ratio.
It is evident that while the mean 24 hour taurine excretion is much greater in F.A. subjects when expressed in terms of |a.M/g creatinine (Table 5) , it is also greater when expressed as absolute excretion in term of body mass (Table 1) . However, before drawing final conclusions, the reproducibility of taurine excretion must be considered. As can be seen from Table I , there were significant differences between the two samplings, both increases and decreases, and there is no evident pattern. We can only draw the conclusion that there is significant random variation in taurine excretion within the same individuals and so the significance of differences between populations becomes questionable. Were the individuals maintained under standard conditions in a metabolic unit, a truly valid comparison could be made, but the expenses and inconvenience of this approach exceed our present capabilities. There is also a significant difference in the mean response of the F.A. subjects to a taurine challenge (Table 5 -6), the mean excretion being much greater than in the controls. Here again the results must be interpreted with caution (a) in view of the great variability in response among the controls and test subjects and (b) because of the lower creatinine levels in F.A. subjects giving a falsely elevated taurine/creatinine ratio.
CONCLUSION
The results of the present studies essentially confirm the previous observations of increased taurine urinary excretion under basal conditions (Lemieux et al., 1976) and after a taurine challenge in Friedreich's disease. However the wide variability in the results, and similar patterns in other neurological disorders with a decreased muscle mass, raise questions about the previous interpretations of these findings. The apparent retention defect in taurine (Barbeau, 1982) may be only a reflection of this decreased muscle mass or of other non-genetic factors, rather than of a defect in tubular reabsorption. The choice of an appropriate neurologically impaired control group with similar disabilities is also a critical factor for the interpretation of the hypothesis. Finally, the authors confirm the unsuitability of creatinine as an index of urinary excretion in subjects with decreased muscle mass or abnormal creatine/ creatinine metabolism.
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